nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabergoline—HTR1D—meninx—peripheral nervous system neoplasm	0.0328	0.113	CbGeAlD
Cabergoline—HTR1B—dura mater—peripheral nervous system neoplasm	0.0312	0.107	CbGeAlD
Cabergoline—HTR1D—dura mater—peripheral nervous system neoplasm	0.0302	0.104	CbGeAlD
Cabergoline—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.0177	0.0607	CbGeAlD
Cabergoline—HTR1B—trigeminal nerve—peripheral nervous system neoplasm	0.0134	0.0461	CbGeAlD
Cabergoline—HTR1D—trigeminal nerve—peripheral nervous system neoplasm	0.013	0.0447	CbGeAlD
Cabergoline—HTR7—vagus nerve—peripheral nervous system neoplasm	0.00968	0.0333	CbGeAlD
Cabergoline—HTR1B—cranial nerve—peripheral nervous system neoplasm	0.00956	0.0329	CbGeAlD
Cabergoline—HTR1D—cranial nerve—peripheral nervous system neoplasm	0.00926	0.0318	CbGeAlD
Cabergoline—DRD5—ganglion—peripheral nervous system neoplasm	0.00782	0.0269	CbGeAlD
Cabergoline—HTR7—cranial nerve—peripheral nervous system neoplasm	0.00737	0.0254	CbGeAlD
Cabergoline—HTR7—pons—peripheral nervous system neoplasm	0.00729	0.0251	CbGeAlD
Cabergoline—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.00645	0.0222	CbGeAlD
Cabergoline—DRD1—nerve—peripheral nervous system neoplasm	0.00605	0.0208	CbGeAlD
Cabergoline—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.00604	0.0208	CbGeAlD
Cabergoline—DRD1—ganglion—peripheral nervous system neoplasm	0.00597	0.0205	CbGeAlD
Cabergoline—HTR1B—ganglion—peripheral nervous system neoplasm	0.00484	0.0166	CbGeAlD
Cabergoline—HTR1D—ganglion—peripheral nervous system neoplasm	0.00468	0.0161	CbGeAlD
Cabergoline—HTR2C—ganglion—peripheral nervous system neoplasm	0.00464	0.016	CbGeAlD
Cabergoline—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.0046	0.0158	CbGeAlD
Cabergoline—HTR2A—pons—peripheral nervous system neoplasm	0.00454	0.0156	CbGeAlD
Cabergoline—HTR1A—ganglion—peripheral nervous system neoplasm	0.00391	0.0134	CbGeAlD
Cabergoline—HTR7—nerve—peripheral nervous system neoplasm	0.00378	0.013	CbGeAlD
Cabergoline—HTR7—ganglion—peripheral nervous system neoplasm	0.00373	0.0128	CbGeAlD
Cabergoline—DRD2—nerve—peripheral nervous system neoplasm	0.00357	0.0123	CbGeAlD
Cabergoline—DRD2—ganglion—peripheral nervous system neoplasm	0.00353	0.0121	CbGeAlD
Cabergoline—DRD1—brainstem—peripheral nervous system neoplasm	0.0026	0.00893	CbGeAlD
Cabergoline—HTR1B—trigeminal ganglion—peripheral nervous system neoplasm	0.00238	0.00817	CbGeAlD
Cabergoline—HTR2A—nerve—peripheral nervous system neoplasm	0.00236	0.0081	CbGeAlD
Cabergoline—HTR2A—ganglion—peripheral nervous system neoplasm	0.00233	0.008	CbGeAlD
Cabergoline—HTR1D—trigeminal ganglion—peripheral nervous system neoplasm	0.0023	0.00791	CbGeAlD
Cabergoline—HTR1B—brainstem—peripheral nervous system neoplasm	0.0021	0.00723	CbGeAlD
Cabergoline—HTR1D—brainstem—peripheral nervous system neoplasm	0.00204	0.007	CbGeAlD
Cabergoline—HTR2C—brainstem—peripheral nervous system neoplasm	0.00202	0.00694	CbGeAlD
Cabergoline—HTR1A—brainstem—peripheral nervous system neoplasm	0.0017	0.00584	CbGeAlD
Cabergoline—ADRA2C—trigeminal ganglion—peripheral nervous system neoplasm	0.00168	0.00579	CbGeAlD
Cabergoline—HTR7—brainstem—peripheral nervous system neoplasm	0.00162	0.00558	CbGeAlD
Cabergoline—ADRA2C—parotid gland—peripheral nervous system neoplasm	0.00159	0.00546	CbGeAlD
Cabergoline—ADRA1A—brainstem—peripheral nervous system neoplasm	0.00156	0.00538	CbGeAlD
Cabergoline—DRD2—brainstem—peripheral nervous system neoplasm	0.00153	0.00527	CbGeAlD
Cabergoline—ADRA2A—trigeminal ganglion—peripheral nervous system neoplasm	0.00134	0.00462	CbGeAlD
Cabergoline—HTR2A—brainstem—peripheral nervous system neoplasm	0.00101	0.00348	CbGeAlD
Cabergoline—HTR1A—cerebellum—peripheral nervous system neoplasm	0.000837	0.00288	CbGeAlD
Cabergoline—HTR7—cerebellum—peripheral nervous system neoplasm	0.0008	0.00275	CbGeAlD
Cabergoline—ADRA1A—cerebellum—peripheral nervous system neoplasm	0.000771	0.00265	CbGeAlD
Cabergoline—DRD2—cerebellum—peripheral nervous system neoplasm	0.000756	0.0026	CbGeAlD
Cabergoline—ADRA2C—cerebellum—peripheral nervous system neoplasm	0.000735	0.00253	CbGeAlD
Cabergoline—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000607	0.00111	CcSEcCtD
Cabergoline—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000606	0.00111	CcSEcCtD
Cabergoline—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000605	0.00111	CcSEcCtD
Cabergoline—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000602	0.00111	CcSEcCtD
Cabergoline—Hot flush—Doxorubicin—peripheral nervous system neoplasm	0.000601	0.0011	CcSEcCtD
Cabergoline—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000601	0.0011	CcSEcCtD
Cabergoline—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000601	0.0011	CcSEcCtD
Cabergoline—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.0006	0.0011	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000599	0.0011	CcSEcCtD
Cabergoline—Menopausal symptoms—Doxorubicin—peripheral nervous system neoplasm	0.000596	0.00109	CcSEcCtD
Cabergoline—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000596	0.00109	CcSEcCtD
Cabergoline—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000596	0.00109	CcSEcCtD
Cabergoline—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000595	0.00109	CcSEcCtD
Cabergoline—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000594	0.00109	CcSEcCtD
Cabergoline—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000591	0.00108	CcSEcCtD
Cabergoline—Malaise—Etoposide—peripheral nervous system neoplasm	0.000589	0.00108	CcSEcCtD
Cabergoline—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000589	0.00108	CcSEcCtD
Cabergoline—Face oedema—Epirubicin—peripheral nervous system neoplasm	0.000587	0.00108	CcSEcCtD
Cabergoline—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000587	0.00108	CcSEcCtD
Cabergoline—ADRA2A—cerebellum—peripheral nervous system neoplasm	0.000587	0.00202	CbGeAlD
Cabergoline—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000584	0.00107	CcSEcCtD
Cabergoline—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000584	0.00107	CcSEcCtD
Cabergoline—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000582	0.00107	CcSEcCtD
Cabergoline—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000582	0.00107	CcSEcCtD
Cabergoline—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000578	0.00106	CcSEcCtD
Cabergoline—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.000576	0.00106	CcSEcCtD
Cabergoline—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000574	0.00105	CcSEcCtD
Cabergoline—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000573	0.00105	CcSEcCtD
Cabergoline—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000573	0.00105	CcSEcCtD
Cabergoline—Rash—Topotecan—peripheral nervous system neoplasm	0.000573	0.00105	CcSEcCtD
Cabergoline—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000572	0.00105	CcSEcCtD
Cabergoline—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000572	0.00105	CcSEcCtD
Cabergoline—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.00057	0.00105	CcSEcCtD
Cabergoline—Headache—Topotecan—peripheral nervous system neoplasm	0.000569	0.00104	CcSEcCtD
Cabergoline—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000568	0.00104	CcSEcCtD
Cabergoline—Rash—Tretinoin—peripheral nervous system neoplasm	0.000568	0.00104	CcSEcCtD
Cabergoline—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000568	0.00104	CcSEcCtD
Cabergoline—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000568	0.00104	CcSEcCtD
Cabergoline—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000567	0.00104	CcSEcCtD
Cabergoline—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000565	0.00104	CcSEcCtD
Cabergoline—Headache—Tretinoin—peripheral nervous system neoplasm	0.000564	0.00104	CcSEcCtD
Cabergoline—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000564	0.00104	CcSEcCtD
Cabergoline—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000564	0.00104	CcSEcCtD
Cabergoline—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000563	0.00103	CcSEcCtD
Cabergoline—Pain—Vincristine—peripheral nervous system neoplasm	0.000563	0.00103	CcSEcCtD
Cabergoline—Constipation—Vincristine—peripheral nervous system neoplasm	0.000563	0.00103	CcSEcCtD
Cabergoline—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.000562	0.00103	CcSEcCtD
Cabergoline—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000562	0.00103	CcSEcCtD
Cabergoline—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000561	0.00103	CcSEcCtD
Cabergoline—Rash—Melphalan—peripheral nervous system neoplasm	0.000561	0.00103	CcSEcCtD
Cabergoline—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00056	0.00103	CcSEcCtD
Cabergoline—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000558	0.00103	CcSEcCtD
Cabergoline—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000555	0.00102	CcSEcCtD
Cabergoline—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000555	0.00102	CcSEcCtD
Cabergoline—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000555	0.00102	CcSEcCtD
Cabergoline—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000549	0.00101	CcSEcCtD
Cabergoline—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000544	0.000998	CcSEcCtD
Cabergoline—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.000543	0.000997	CcSEcCtD
Cabergoline—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000543	0.000996	CcSEcCtD
Cabergoline—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00054	0.000991	CcSEcCtD
Cabergoline—Nausea—Topotecan—peripheral nervous system neoplasm	0.00054	0.00099	CcSEcCtD
Cabergoline—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000538	0.000988	CcSEcCtD
Cabergoline—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000538	0.000988	CcSEcCtD
Cabergoline—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000537	0.000987	CcSEcCtD
Cabergoline—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000535	0.000983	CcSEcCtD
Cabergoline—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000535	0.000983	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00053	0.000973	CcSEcCtD
Cabergoline—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000528	0.00097	CcSEcCtD
Cabergoline—Nausea—Melphalan—peripheral nervous system neoplasm	0.000528	0.00097	CcSEcCtD
Cabergoline—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000527	0.000967	CcSEcCtD
Cabergoline—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000525	0.000965	CcSEcCtD
Cabergoline—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000522	0.000959	CcSEcCtD
Cabergoline—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00052	0.000955	CcSEcCtD
Cabergoline—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000519	0.000953	CcSEcCtD
Cabergoline—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000519	0.000952	CcSEcCtD
Cabergoline—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000515	0.000946	CcSEcCtD
Cabergoline—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000514	0.000943	CcSEcCtD
Cabergoline—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000514	0.000943	CcSEcCtD
Cabergoline—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000508	0.000933	CcSEcCtD
Cabergoline—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000506	0.000928	CcSEcCtD
Cabergoline—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000505	0.000928	CcSEcCtD
Cabergoline—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000504	0.000925	CcSEcCtD
Cabergoline—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000503	0.000924	CcSEcCtD
Cabergoline—HTR2A—cerebellum—peripheral nervous system neoplasm	0.000499	0.00172	CbGeAlD
Cabergoline—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000498	0.000914	CcSEcCtD
Cabergoline—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000498	0.000914	CcSEcCtD
Cabergoline—Pain—Cisplatin—peripheral nervous system neoplasm	0.000498	0.000913	CcSEcCtD
Cabergoline—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00049	0.000899	CcSEcCtD
Cabergoline—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000488	0.000896	CcSEcCtD
Cabergoline—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000486	0.000892	CcSEcCtD
Cabergoline—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000485	0.00089	CcSEcCtD
Cabergoline—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000483	0.000887	CcSEcCtD
Cabergoline—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000479	0.00088	CcSEcCtD
Cabergoline—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000479	0.000879	CcSEcCtD
Cabergoline—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000478	0.000878	CcSEcCtD
Cabergoline—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000475	0.000873	CcSEcCtD
Cabergoline—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000475	0.000872	CcSEcCtD
Cabergoline—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000474	0.00087	CcSEcCtD
Cabergoline—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000472	0.000867	CcSEcCtD
Cabergoline—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000471	0.000865	CcSEcCtD
Cabergoline—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000468	0.00086	CcSEcCtD
Cabergoline—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000468	0.000858	CcSEcCtD
Cabergoline—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000467	0.000858	CcSEcCtD
Cabergoline—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000464	0.000852	CcSEcCtD
Cabergoline—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000463	0.000851	CcSEcCtD
Cabergoline—Fatigue—Etoposide—peripheral nervous system neoplasm	0.00046	0.000844	CcSEcCtD
Cabergoline—Constipation—Etoposide—peripheral nervous system neoplasm	0.000456	0.000837	CcSEcCtD
Cabergoline—Pain—Etoposide—peripheral nervous system neoplasm	0.000456	0.000837	CcSEcCtD
Cabergoline—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000455	0.000836	CcSEcCtD
Cabergoline—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000452	0.000829	CcSEcCtD
Cabergoline—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000452	0.000829	CcSEcCtD
Cabergoline—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00045	0.000826	CcSEcCtD
Cabergoline—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000442	0.000812	CcSEcCtD
Cabergoline—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000442	0.000811	CcSEcCtD
Cabergoline—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.00044	0.000807	CcSEcCtD
Cabergoline—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000439	0.000806	CcSEcCtD
Cabergoline—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000437	0.000803	CcSEcCtD
Cabergoline—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000436	0.0008	CcSEcCtD
Cabergoline—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000436	0.0008	CcSEcCtD
Cabergoline—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000435	0.000799	CcSEcCtD
Cabergoline—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000434	0.000797	CcSEcCtD
Cabergoline—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000431	0.00079	CcSEcCtD
Cabergoline—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00043	0.00079	CcSEcCtD
Cabergoline—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000429	0.000787	CcSEcCtD
Cabergoline—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000428	0.000785	CcSEcCtD
Cabergoline—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000422	0.000774	CcSEcCtD
Cabergoline—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000421	0.000774	CcSEcCtD
Cabergoline—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000421	0.000774	CcSEcCtD
Cabergoline—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000418	0.000768	CcSEcCtD
Cabergoline—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000417	0.000766	CcSEcCtD
Cabergoline—Rash—Vincristine—peripheral nervous system neoplasm	0.000415	0.000762	CcSEcCtD
Cabergoline—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000414	0.000761	CcSEcCtD
Cabergoline—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000414	0.000761	CcSEcCtD
Cabergoline—Headache—Vincristine—peripheral nervous system neoplasm	0.000412	0.000757	CcSEcCtD
Cabergoline—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000409	0.000751	CcSEcCtD
Cabergoline—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000406	0.000745	CcSEcCtD
Cabergoline—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000405	0.000744	CcSEcCtD
Cabergoline—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000398	0.000731	CcSEcCtD
Cabergoline—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000393	0.000721	CcSEcCtD
Cabergoline—Nausea—Vincristine—peripheral nervous system neoplasm	0.000391	0.000718	CcSEcCtD
Cabergoline—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.00039	0.000717	CcSEcCtD
Cabergoline—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.00039	0.000716	CcSEcCtD
Cabergoline—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000383	0.000704	CcSEcCtD
Cabergoline—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000382	0.000702	CcSEcCtD
Cabergoline—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000377	0.000692	CcSEcCtD
Cabergoline—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000376	0.00069	CcSEcCtD
Cabergoline—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000375	0.000688	CcSEcCtD
Cabergoline—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000372	0.000682	CcSEcCtD
Cabergoline—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00037	0.000679	CcSEcCtD
Cabergoline—Rash—Cisplatin—peripheral nervous system neoplasm	0.000367	0.000673	CcSEcCtD
Cabergoline—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000367	0.000673	CcSEcCtD
Cabergoline—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000365	0.00067	CcSEcCtD
Cabergoline—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000361	0.000663	CcSEcCtD
Cabergoline—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000361	0.000662	CcSEcCtD
Cabergoline—Tension—Epirubicin—peripheral nervous system neoplasm	0.000359	0.00066	CcSEcCtD
Cabergoline—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000356	0.000653	CcSEcCtD
Cabergoline—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000354	0.00065	CcSEcCtD
Cabergoline—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000352	0.000647	CcSEcCtD
Cabergoline—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000352	0.000646	CcSEcCtD
Cabergoline—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000348	0.000638	CcSEcCtD
Cabergoline—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000346	0.000634	CcSEcCtD
Cabergoline—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000344	0.000631	CcSEcCtD
Cabergoline—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.00034	0.000624	CcSEcCtD
Cabergoline—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000339	0.000622	CcSEcCtD
Cabergoline—Rash—Etoposide—peripheral nervous system neoplasm	0.000336	0.000617	CcSEcCtD
Cabergoline—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000336	0.000616	CcSEcCtD
Cabergoline—Headache—Etoposide—peripheral nervous system neoplasm	0.000334	0.000613	CcSEcCtD
Cabergoline—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000334	0.000613	CcSEcCtD
Cabergoline—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.00061	CcSEcCtD
Cabergoline—Malaise—Epirubicin—peripheral nervous system neoplasm	0.00033	0.000606	CcSEcCtD
Cabergoline—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000329	0.000604	CcSEcCtD
Cabergoline—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000329	0.000604	CcSEcCtD
Cabergoline—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000328	0.000603	CcSEcCtD
Cabergoline—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000328	0.000602	CcSEcCtD
Cabergoline—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000326	0.000598	CcSEcCtD
Cabergoline—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000324	0.000594	CcSEcCtD
Cabergoline—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000322	0.000591	CcSEcCtD
Cabergoline—Nausea—Etoposide—peripheral nervous system neoplasm	0.000317	0.000581	CcSEcCtD
Cabergoline—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000316	0.00058	CcSEcCtD
Cabergoline—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000314	0.000577	CcSEcCtD
Cabergoline—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000312	0.000572	CcSEcCtD
Cabergoline—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000311	0.00057	CcSEcCtD
Cabergoline—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000308	0.000565	CcSEcCtD
Cabergoline—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000305	0.000561	CcSEcCtD
Cabergoline—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000305	0.00056	CcSEcCtD
Cabergoline—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000304	0.000559	CcSEcCtD
Cabergoline—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000304	0.000558	CcSEcCtD
Cabergoline—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000301	0.000553	CcSEcCtD
Cabergoline—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.00055	CcSEcCtD
Cabergoline—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000299	0.000549	CcSEcCtD
Cabergoline—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.000547	CcSEcCtD
Cabergoline—Shock—Epirubicin—peripheral nervous system neoplasm	0.000294	0.00054	CcSEcCtD
Cabergoline—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.000537	CcSEcCtD
Cabergoline—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000289	0.00053	CcSEcCtD
Cabergoline—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000288	0.000529	CcSEcCtD
Cabergoline—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000287	0.000528	CcSEcCtD
Cabergoline—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000285	0.000523	CcSEcCtD
Cabergoline—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000285	0.000523	CcSEcCtD
Cabergoline—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000518	CcSEcCtD
Cabergoline—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000279	0.000513	CcSEcCtD
Cabergoline—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000279	0.000512	CcSEcCtD
Cabergoline—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.000508	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000272	0.0005	CcSEcCtD
Cabergoline—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000272	0.000499	CcSEcCtD
Cabergoline—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.00027	0.000496	CcSEcCtD
Cabergoline—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000268	0.000493	CcSEcCtD
Cabergoline—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.000491	CcSEcCtD
Cabergoline—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000266	0.000489	CcSEcCtD
Cabergoline—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000266	0.000488	CcSEcCtD
Cabergoline—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000264	0.000484	CcSEcCtD
Cabergoline—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000263	0.000483	CcSEcCtD
Cabergoline—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.00026	0.000477	CcSEcCtD
Cabergoline—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000258	0.000474	CcSEcCtD
Cabergoline—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000258	0.000473	CcSEcCtD
Cabergoline—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000469	CcSEcCtD
Cabergoline—Pain—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000469	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000462	CcSEcCtD
Cabergoline—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.000459	CcSEcCtD
Cabergoline—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000456	CcSEcCtD
Cabergoline—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000452	CcSEcCtD
Cabergoline—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000246	0.000452	CcSEcCtD
Cabergoline—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000451	CcSEcCtD
Cabergoline—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000244	0.000449	CcSEcCtD
Cabergoline—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000447	CcSEcCtD
Cabergoline—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000441	CcSEcCtD
Cabergoline—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000438	CcSEcCtD
Cabergoline—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000434	CcSEcCtD
Cabergoline—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000434	CcSEcCtD
Cabergoline—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000236	0.000434	CcSEcCtD
Cabergoline—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000418	CcSEcCtD
Cabergoline—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000415	CcSEcCtD
Cabergoline—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00022	0.000404	CcSEcCtD
Cabergoline—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.000401	CcSEcCtD
Cabergoline—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000214	0.000394	CcSEcCtD
Cabergoline—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000211	0.000388	CcSEcCtD
Cabergoline—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000375	CcSEcCtD
Cabergoline—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000374	CcSEcCtD
Cabergoline—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000364	CcSEcCtD
Cabergoline—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000363	CcSEcCtD
Cabergoline—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000359	CcSEcCtD
Cabergoline—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00019	0.000349	CcSEcCtD
Cabergoline—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000347	CcSEcCtD
Cabergoline—Rash—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000346	CcSEcCtD
Cabergoline—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000346	CcSEcCtD
Cabergoline—Headache—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000344	CcSEcCtD
Cabergoline—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000336	CcSEcCtD
Cabergoline—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000326	CcSEcCtD
Cabergoline—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000323	CcSEcCtD
Cabergoline—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.00032	CcSEcCtD
Cabergoline—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.00032	CcSEcCtD
Cabergoline—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000318	CcSEcCtD
Cabergoline—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000301	CcSEcCtD
Cabergoline—ADRA2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.29e-05	0.0002	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.29e-05	0.0002	CbGpPWpGaD
Cabergoline—DRD5—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.23e-05	0.000196	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.22e-05	0.000196	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.2e-05	0.000194	CbGpPWpGaD
Cabergoline—ADRA2C—Hemostasis—HRAS—peripheral nervous system neoplasm	3.2e-05	0.000194	CbGpPWpGaD
Cabergoline—HTR2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.2e-05	0.000194	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.17e-05	0.000192	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.14e-05	0.000191	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.14e-05	0.000191	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.1e-05	0.000188	CbGpPWpGaD
Cabergoline—ADRA2B—Hemostasis—AKT1—peripheral nervous system neoplasm	3.02e-05	0.000184	CbGpPWpGaD
Cabergoline—DRD1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.01e-05	0.000183	CbGpPWpGaD
Cabergoline—DRD3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.97e-05	0.000181	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.97e-05	0.000181	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.96e-05	0.00018	CbGpPWpGaD
Cabergoline—DRD5—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.93e-05	0.000178	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.92e-05	0.000178	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.92e-05	0.000178	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.88e-05	0.000175	CbGpPWpGaD
Cabergoline—ADRA2C—Hemostasis—AKT1—peripheral nervous system neoplasm	2.82e-05	0.000172	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.72e-05	0.000165	CbGpPWpGaD
Cabergoline—ADRA2A—Hemostasis—TP53—peripheral nervous system neoplasm	2.72e-05	0.000165	CbGpPWpGaD
Cabergoline—ADRB1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.71e-05	0.000165	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.7e-05	0.000164	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.69e-05	0.000163	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.68e-05	0.000163	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.66e-05	0.000162	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.65e-05	0.000161	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.64e-05	0.000161	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.64e-05	0.00016	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.6e-05	0.000158	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.6e-05	0.000158	CbGpPWpGaD
Cabergoline—ADRA2A—Hemostasis—HRAS—peripheral nervous system neoplasm	2.6e-05	0.000158	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.59e-05	0.000158	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.58e-05	0.000157	CbGpPWpGaD
Cabergoline—HTR7—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.56e-05	0.000156	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.55e-05	0.000155	CbGpPWpGaD
Cabergoline—HTR1D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.54e-05	0.000155	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.53e-05	0.000154	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.51e-05	0.000152	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.5e-05	0.000152	CbGpPWpGaD
Cabergoline—HTR1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.49e-05	0.000151	CbGpPWpGaD
Cabergoline—HTR7—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.49e-05	0.000151	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.48e-05	0.000151	CbGpPWpGaD
Cabergoline—HTR1D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.47e-05	0.00015	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.47e-05	0.00015	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.47e-05	0.00015	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.46e-05	0.00015	CbGpPWpGaD
Cabergoline—DRD4—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.45e-05	0.000149	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.45e-05	0.000149	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.43e-05	0.000147	CbGpPWpGaD
Cabergoline—HTR1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.42e-05	0.000147	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.4e-05	0.000146	CbGpPWpGaD
Cabergoline—DRD4—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.38e-05	0.000145	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.36e-05	0.000143	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.34e-05	0.000142	CbGpPWpGaD
Cabergoline—HTR2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.34e-05	0.000142	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.31e-05	0.00014	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.31e-05	0.00014	CbGpPWpGaD
Cabergoline—ADRA2A—Hemostasis—AKT1—peripheral nervous system neoplasm	2.29e-05	0.000139	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.28e-05	0.000138	CbGpPWpGaD
Cabergoline—HTR2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.27e-05	0.000138	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	2.26e-05	0.000138	CbGpPWpGaD
Cabergoline—HTR7—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.26e-05	0.000137	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.25e-05	0.000137	CbGpPWpGaD
Cabergoline—HTR1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.24e-05	0.000136	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.24e-05	0.000136	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.24e-05	0.000136	CbGpPWpGaD
Cabergoline—DRD1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.21e-05	0.000134	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.2e-05	0.000134	CbGpPWpGaD
Cabergoline—HTR1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.2e-05	0.000134	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.19e-05	0.000133	CbGpPWpGaD
Cabergoline—DRD3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.18e-05	0.000132	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.18e-05	0.000132	CbGpPWpGaD
Cabergoline—DRD4—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.16e-05	0.000132	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.15e-05	0.000131	CbGpPWpGaD
Cabergoline—DRD1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.14e-05	0.00013	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.12e-05	0.000129	CbGpPWpGaD
Cabergoline—DRD3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.12e-05	0.000129	CbGpPWpGaD
Cabergoline—ADRA1D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.12e-05	0.000129	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.1e-05	0.000128	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.1e-05	0.000127	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.1e-05	0.000127	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.09e-05	0.000127	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.07e-05	0.000126	CbGpPWpGaD
Cabergoline—HTR2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.06e-05	0.000126	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.06e-05	0.000125	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.05e-05	0.000125	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.05e-05	0.000125	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.04e-05	0.000124	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.01e-05	0.000122	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.01e-05	0.000122	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2e-05	0.000122	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2e-05	0.000122	CbGpPWpGaD
Cabergoline—ADRB1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.98e-05	0.000121	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.98e-05	0.00012	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.96e-05	0.000119	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.96e-05	0.000119	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.95e-05	0.000118	CbGpPWpGaD
Cabergoline—DRD1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.95e-05	0.000118	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.94e-05	0.000118	CbGpPWpGaD
Cabergoline—ADRB1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.93e-05	0.000117	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.92e-05	0.000117	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.92e-05	0.000117	CbGpPWpGaD
Cabergoline—DRD3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.92e-05	0.000117	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.92e-05	0.000117	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.91e-05	0.000116	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	1.91e-05	0.000116	CbGpPWpGaD
Cabergoline—ADRA2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.91e-05	0.000116	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.91e-05	0.000116	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.9e-05	0.000115	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.89e-05	0.000115	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.89e-05	0.000115	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.89e-05	0.000115	CbGpPWpGaD
Cabergoline—ADRB2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.89e-05	0.000115	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.87e-05	0.000114	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.87e-05	0.000114	CbGpPWpGaD
Cabergoline—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.84e-05	0.000112	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.84e-05	0.000112	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.84e-05	0.000112	CbGpPWpGaD
Cabergoline—HTR2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.83e-05	0.000112	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.83e-05	0.000111	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.82e-05	0.000111	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.82e-05	0.00011	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.81e-05	0.00011	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	1.8e-05	0.000109	CbGpPWpGaD
Cabergoline—ADRA2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.78e-05	0.000108	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.78e-05	0.000108	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.77e-05	0.000107	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.77e-05	0.000107	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.76e-05	0.000107	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.76e-05	0.000107	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.76e-05	0.000107	CbGpPWpGaD
Cabergoline—ADRA1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.76e-05	0.000107	CbGpPWpGaD
Cabergoline—ADRB1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.75e-05	0.000106	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.74e-05	0.000106	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.74e-05	0.000106	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.73e-05	0.000105	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.73e-05	0.000105	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.71e-05	0.000104	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.7e-05	0.000104	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.67e-05	0.000102	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.67e-05	0.000101	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.67e-05	0.000101	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.66e-05	0.000101	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.64e-05	9.96e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.64e-05	9.95e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.64e-05	9.95e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.62e-05	9.85e-05	CbGpPWpGaD
Cabergoline—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.62e-05	9.84e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.6e-05	9.75e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.6e-05	9.75e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.6e-05	9.73e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.59e-05	9.69e-05	CbGpPWpGaD
Cabergoline—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.59e-05	9.68e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.59e-05	9.64e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.58e-05	9.62e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.58e-05	9.61e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.58e-05	9.6e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.57e-05	9.55e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.57e-05	9.52e-05	CbGpPWpGaD
Cabergoline—ADRA1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.56e-05	9.48e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.55e-05	9.4e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.54e-05	9.35e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.53e-05	9.31e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.52e-05	9.26e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.51e-05	9.2e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.51e-05	9.19e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.5e-05	9.13e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.49e-05	9.07e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.49e-05	9.06e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.48e-05	9.01e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.48e-05	8.98e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.47e-05	8.94e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.47e-05	8.94e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	1.47e-05	8.92e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.46e-05	8.87e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.46e-05	8.87e-05	CbGpPWpGaD
Cabergoline—ADRA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.45e-05	8.81e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.45e-05	8.8e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.45e-05	8.79e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.44e-05	8.78e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	1.44e-05	8.75e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.44e-05	8.73e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.43e-05	8.67e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.42e-05	8.63e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.42e-05	8.61e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.38e-05	8.4e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.38e-05	8.39e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.36e-05	8.28e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.36e-05	8.26e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.34e-05	8.17e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.34e-05	8.17e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.34e-05	8.17e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.33e-05	8.12e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.33e-05	8.06e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.32e-05	8.04e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.32e-05	8e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.3e-05	7.92e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.3e-05	7.89e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.3e-05	7.88e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.29e-05	7.81e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.29e-05	7.81e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.28e-05	7.77e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.25e-05	7.61e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.23e-05	7.49e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.22e-05	7.45e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.22e-05	7.42e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.21e-05	7.38e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.21e-05	7.34e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.2e-05	7.32e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.2e-05	7.28e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.17e-05	7.12e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.17e-05	7.12e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.17e-05	7.08e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.16e-05	7.06e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.15e-05	6.99e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.15e-05	6.97e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—AKT1—peripheral nervous system neoplasm	1.14e-05	6.96e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.14e-05	6.9e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.14e-05	6.9e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.13e-05	6.89e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.12e-05	6.82e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.12e-05	6.81e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.12e-05	6.78e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.11e-05	6.78e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.08e-05	6.59e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.07e-05	6.49e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.03e-05	6.29e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.03e-05	6.25e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.02e-05	6.23e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.01e-05	6.15e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.01e-05	6.15e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.91e-06	6.02e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.89e-06	6.01e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.84e-06	5.98e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.84e-06	5.98e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.68e-06	5.88e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.57e-06	5.82e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.48e-06	5.76e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.42e-06	5.73e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—AKT1—peripheral nervous system neoplasm	9.3e-06	5.65e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.21e-06	5.6e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.81e-06	5.35e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.69e-06	5.28e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.55e-06	5.2e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.37e-06	5.09e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.77e-06	4.73e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	3.96e-06	2.41e-05	CbGpPWpGaD
